Valeant to examine ties with speciality pharmacy
It discloses it had acquired an option to buy Philidor, which dispenses some of its dermatology drugs
New York
EMBATTLED Valeant Pharmaceuticals International said on Monday that its accounting related to its relationship with a speciality pharmacy was legal and appropriate, but added that its board was nonetheless forming a special committee to investigate the relationship.
Valeant, based in Laval, Quebec, disclosed for the first time last week that it had acquired an option to buy the speciality pharmacy, Philidor Rx Services, which dispenses some of Valeant's dermatology drugs. That alone was controversial because such pharmacies can be used to promote high-priced drugs, and Valeant was already being scrutinised by lawmakers, the news media and federal prosecutors for sharply raising drug prices.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action